Samonte, Editha .

HRN: 23-54-44  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/18/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
08/18/2023
08/25/2023
IV
4.5g
Q8
CAP-HR
Waiting Final Action 
08/19/2023
SILVER SULFADIAZINE 1%, 25G CREAM (TUBE)
08/19/2023
08/26/2023
APPLY TO SKIN
N/A
BID
Empiric
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: